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BSID-II  Bayley Scales of Infant Development, version II 
CI   Confidence Interval   
DDE   1,1’-dichloro-2,2’-bis(4-chlorophenyl)ethylene 
ΣDAP   sum of dialkylphosphate metabolites 
ΣDEP   sum of diethylphosphate metabolites 
ΣDMP   sum of dimethylphosphate metabolites 
FSIQ    full-scale IQ 
HOME   Home Observation for Measurement of the Environment 
MDI   Mental Development Index 
OP   organophosphate 
PCBs   polychlorinated biphenyls 
PDI   Psychomotor Development Index 
PON1   paraoxonase 1 
SD   Standard deviation 
WISC-IV  Wechsler Intelligence Scale for Children - Fourth Edition 
WPPSI-III  Wechsler Preschool and Primary Scale of Intelligence - Third Edition  
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ABSTRACT 
Background: Prenatal exposure to organophosphate pesticides has been shown to negatively impact 
child neurobehavioral development. Paraoxonase 1 (PON1) is a key enzyme in the metabolism of 
organophosphates.  
Objective: To examine the relationship between biomarkers of organophosphate exposure, PON1, and 
cognitive development at ages 12 and 24 months, and 6 to 9 years. 
Methods: The Mount Sinai Children’s Environmental Health Study enrolled a multiethnic prenatal 
population in New York City between 1998 and 2002 (n= 404). Third trimester maternal urines were 
collected and analyzed for organophosphate metabolites (n = 360). Prenatal maternal blood was 
analyzed for PON1 activity and genotype. Children returned for neurodevelopment assessments at ages 
12 months (n = 200), 24 months (n = 276), 6 to 9 (n = 169) years.  
Results: Prenatal total dialkylphosphate metabolite level was associated with a decrement in mental 
development at 12 months among blacks and Hispanics. These associations appeared to be enhanced 
among children of mothers who carried the PON1 Q192R QQ genotype, which imparts slow catalytic 
activity for chlorpyrifos oxon. In later childhood, increasing prenatal total dialkyl- and dimethylphosphate 
metabolites were associated with decrements in perceptual reasoning in the maternal PON1 Q192R QQ 
genotype, with a monotonic trend consistent with greater decrements with increasing prenatal exposure. 
Conclusion: Our findings suggest that prenatal exposure to organophosphates negatively impacts 
cognitive development, particularly perceptual reasoning, with evidence of effects beginning at 12 months 
and continuing through early childhood. PON1 may be an important susceptibility factor for these 
deleterious effects.  
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Background 
Prior to 2001, residential exposure to organophosphate pesticides, including chlorpyrifos and diazinon, 
was common, even in an urban setting. Insecticides are used in multi-unit, inner city dwellings to control 
insect and rodent infestations within apartments, in common spaces, and around building exteriors. 
Despite the voluntary cancellation of residential use registrations of chlorpyrifos and diazinon in 2001 and 
2004 respectively, between June 2005 and March 2006, 78% of randomly selected nationally 
representative US homes had measurable levels of chlorpyrifos, and 35% had measurable levels of 
diazinon, suggesting ongoing residential exposure (Stout et al. 2009). Additionally, exposure to 
organophosphate pesticides or their residues may occur via consumption of conventionally grown fruits 
and vegetables (Lu et al. 2008). 
 
Neurodevelopmental consequences of human exposure to organophosphate pesticides have been 
demonstrated in urban (Bouchard et al. 2010; Engel et al. 2007; Rauh et al. 2006), rural (Eskenazi et al. 
2010; Eskenazi et al. 2007; Young et al. 2005), and occupational settings (Handal et al. 2008; Roldan-
Tapia et al. 2006), some of which specifically involve prenatal exposure (Engel et al. 2007; Eskenazi et 
al. 2010; Eskenazi et al. 2007; Marks et al. 2010; Rauh et al. 2006; Young et al. 2005). We have 
previously reported that prenatal pesticide exposure was associated with smaller head circumference 
(Berkowitz et al. 2004), and more abnormal primitive reflexes (Engel et al. 2007), particularly among 
children of mothers with low paraoxonase 1 (PON1) activity. PON1 is a key enzyme in the metabolism of 
organophosphate pesticides (Costa et al. 1999), and has been shown to be a biomarker of susceptibility 
to the toxic effects of organophophate pesticides, both in animals (Costa et al. 2003), and in humans 
(Engel et al. 2007; Eskenazi et al. 2010; Lee et al. 2003; Nielsen et al. 2010).  
 
Objective 
We undertook an investigation of the impact of prenatal organophosphate metabolite biomarker levels in 
relation to cognitive development at multiple times in childhood, while considering the modifying influence 
of maternal and child PON1 genotype and enzymatic activity.  
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Methods 
The Mount Sinai Children’s Environmental Health Cohort study is a prospective multiethnic cohort that 
enrolled primiparous women who presented for prenatal care with singleton pregnancies at the Mount 
Sinai prenatal clinic and two private practices, and were subsequently delivered at Mount Sinai Hospital 
between May 1998 and July 2001. The target population was healthy, first born infants with no underlying 
health conditions that might independently result in serious neurodevelopmental impairment. Therefore, 
women were considered eligible if they were primiparous with singleton pregnancies, had no underlying 
health conditions that might predispose them to have serious complications of pregnancy that might 
result in an at-risk infant, and ultimately delivered infants that were neither extremely preterm nor very 
low birth weight. (Berkowitz et al. 2003; Berkowitz et al. 2004) Mother-infant pairs were recruited early in 
pregnancy (n = 479). In brief, subsequent to delivery, 75 women were excluded because of medical 
complications, very premature births (delivery before 32 completed weeks or less than 1500 grams), 
delivery of an infant with a birth defect, inability to collect biologic specimens before birth, change of 
hospital or residence outside New York City, or refusal to continue to participate, leaving 404 women-
infant pairs in the final cohort (Berkowitz et al. 2004).  
 
We administered a questionnaire to participants during their third trimester of pregnancy to obtain 
information on environmental exposures, sociodemographic characteristics, obstetrical and medical 
history, and lifestyle factors. Women self-identified as white, white Hispanic, black, black Hispanic, or 
other. For the purpose of this analysis, white Hispanic and black Hispanics were jointly considered 
Hispanic. Maternal blood and urine samples were also obtained during a routine clinical visit, generally 
between 26 and 28 weeks of gestation. Delivery characteristics and birth outcomes, including birth 
weight, length, head circumference, gestational age and infant gender, were obtained from a 
computerized perinatal database within the Department of Obstetrics, Gynecology and Reproductive 
Science at Mount Sinai Hospital.  
 
The Bayley Scales of Infant Development (version II, BSID-II) was administered at the Mount Sinai 
Hospital at approximately 12 (n=200) and 24 months (n=276).  The BSID-II provides age-standardized 
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norms of mental (MDI) and psychomotor (PDI) development. The MDI rates the child’s cognitive ability in 
a number of areas, including memory, habituation, problem solving, early number concepts, 
generalization, classification, vocalizations, language and social skills. The PDI rates the child’s fine and 
gross motor coordination. Scales are age-standardized to mean = 100, SD = 15 (Bayley 1993). 
Interviews and examinations were conducted in English or Spanish as required. Children were invited to 
return for Wechsler psychometric intelligence tests between the ages of 6 and 9 years. Children that 
returned before 7 years of age were administered the Wechsler Preschool and Primary Scale of 
Intelligence - Third Edition (WPPSI-III). The WPPSI-III was administered in English or Spanish by one of 
4 examiners. Block Design, Information, Matrix Reasoning, Vocabulary, Picture Concepts, Symbol 
Search, Word Reasoning, and Coding subtests were completed. Composite Verbal, Performance, 
Processing Speed, and Full-Scale IQ scores were derived using age-standardized WPPSI-III norms. 
Children who returned between the ages of 7 and 9 years were administered the Wechsler Intelligence 
Scale for Children - Fourth Edition (WISC-IV) by one of 4 examiners. Children provided witnessed assent 
prior to the start of the assessment. Block Design, Similarities, Digit Span, Picture Concepts, Coding, 
Vocabulary, Letter-Number Sequence, Matrix Reasoning, Comprehension and Symbol Search subtests 
were completed.  Composite Verbal, Perceptual Reasoning, Working Memory, Processing Speed, and 
Full-Scale IQ scores were derived using age-standardized WISC-IV norms. Both the WPPSI-III and the 
WISC-IV were administered in a private room without the parent present. Mothers provided informed 
consent and children aged 7 and older provided verbal and witnessed assent. This study was approved 
by the Institutional Review Board of Mount Sinai School of Medicine.  
Maternal urine samples were analyzed by the Centers for Disease Control and Prevention for six 
dialkylphosphate metabolites in two batches. Laboratory and quality control methods have been reported 
previously (Barr et al. 2005; Bravo et al. 2004; Wolff et al. 2005). In some cases, individual 
dialkylphosphate metabolite levels were missing due to analytic interference. In these cases, missing 
dialkylphosphate metabolite levels were imputed using regression analysis to predict the missing 
metabolite on the basis of the other non-missing metabolites measured for that woman within the group 
of correlated metabolites, as has been previously described (Engel et al. 2007). Samples below the LOD 
were defined as LOD/√2. Diethyl- and dimethyl-phosphate metabolites were summed (as µm/L) to obtain 
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diethylphosphate (ΣDEP) and dimethylphosphate (ΣDMP) metabolites, respectively, and total 
dialkylphosphate (ΣDAP) levels. Very dilute samples of urine with < 20 µg/dL creatinine (n = 26) were 
excluded from organophosphate metabolite analyses, in accordance with methods that have previously 
been applied for spot urine biomarker measures (Carrieri et al. 2001; Engel et al. 2007; Eskenazi et al. 
2004; Wolff et al. 2007). Overall, approximately 97%, 89%, and 90% of the cohort had detectable levels 
of ΣDAP, ΣDEP, and ΣDMP metabolites respectively (Engel et al. 2007). A random subset of maternal 
peripheral blood samples from the entire cohort (n = 194), distributed roughly equally by maternal 
race/ethnicity (66 blacks, 64 Hispanics, 64 whites, the number being dictated by budgetary 
considerations), was analyzed for polychlorinated biphenyls (PCBs) and 1,1’-dichloro-2,2’-bis(4-
chlorophenyl)ethylene (DDE). PCBs were defined as the sum of congeners 118, 153, 138, and 180 
(Wolff et al. 2005). Total lipids (g/liter) were calculated by using cholesterol and triglycerides (Phillips et 
al. 1989) determined on the 174 plasma samples with sufficient volume. Distributions of biomarker levels 
have been previously reported (Engel et al. 2007; Wolff et al. 2007). 
 
Plasma was separated from prenatal maternal peripheral blood and cord blood at delivery, and was used 
to measure PON1 activity by phenylacetate hydrolysis (Chen et al. 2005). Using maternal and child DNA, 
PON1 polymorphisms were also measured using clamp-dependent and linking emulsion allele-specific 
PCR (Chen et al. 2005). We examined interactions between prenatal organophosphate exposure 
(dichotomized as above and below the median exposure) and tertiles of PON1 activity in maternal 
prenatal peripheral blood and child cord blood. We also examined interactions between prenatal 
organophosphate exposure and the maternal or child PON1 Q192R, -108C>T, and L55M 
polymorphisms. We closely examined interactions if the type 3 F-test for the product-term in Proc GLM 
(either the class variable representing biomarker tertiles * dichotomized genotypes or race/ethnicity, or 
the linear term for log10 organophosphate metabolites * dichotomized genotypes or race/ethnicity) was p 
< 0.20. The PON1 Q192R polymorphism in particular has been shown to have a strong functional 
consequence on the relative rate of hydrolysis of certain organophophate substrates (Li et al. 2000), and 
has been shown to affect the catalytic efficiency for chlorpyrifos but not diazinon (Richter et al. 2009).  
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Data were analyzed using the SAS system version 9.1 (Cary, NC). Generalized linear models were used 
to analyze the relationship between biomarker levels and the Mental and Psychomotor Development 
Indices (MDI and PDI respectively). In total, 200 children were administered the BSID-II at approximately 
12-months of age (mean 13.1 ± SD=1.6 months). Children were excluded from analyses if their refusal to 
do a large proportion of the items on the exam influenced their overall score (12-month MDI n = 1). Two 
children were excluded from the 12-month analysis because their parent reported a diagnosis of 
pervasive developmental disorder. We also excluded observations when urine creatinine was < 20 µg/dL 
in maternal urine sample (n = 20). Of the remaining 177 eligible children who completed 12-month 
exams, 174 had organophosphate metabolites measured in prenatal urine.  
 
At the 24-month BSID-II (mean 27.4 ± SD=4.5 months), 276 children completed the exam. Two were 
excluded from the 24-month analysis because the parent reported a diagnosis of pervasive 
developmental disorder. Samples of urine < 20 µg/dL creatinine (n = 23) were also excluded. Of the 
remaining 251 eligible observations, 247 had organophosphate metabolites measured in prenatal urine. 
We could not compute the MDI scores for ten additional children because their refusals were too 
extensive to accurately calculate scores; however, they were included in the PDI analyses because their 
scores were valid..   
 
In order to maximize the sample size of our models, we conducted analyses that combined the full-scale 
IQ (FSIQ), perceptual reasoning, verbal comprehension, and processing speed composite scores from 
children who came for at least one of the Wechsler psychometric intelligence exams—in the text & tables 
we refer to as the “combined populations” (n = 169). For these analyses, we preferentially selected the 
WISC-IV composite scores, and substituted the WPPSI-III composite scores if the child did not return for 
the later exam. We included an indicator variable to account for whether the scores derived from a WISC-
IV or WPPSI-III exam. The convergent validity between the WISC-IV and WPPSI-III has been previously 
reported. Specifically, in psychometric analyses, the correlation between WPPSI-III and WISC-IV FSIQ 
scores was 0.89, WPPSI-III Verbal IQ versus WISC-IV Verbal Comprehension = 0.83, WPPSI-III 
Performance IQ versus WISC-IV Perceptual Reasoning = 0.79 (Flanagan and Kaufman 2004). In our 
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study, among children who returned for both exams (n = 103), the correlations between the composite 
scores on the WPPSI-III and WISC-IV were likewise very strong: FSIQ = 0.83, Verbal IQ/Verbal 
Comprehension = 0.84, and Performance IQ/Perceptual Reasoning = 0.78. For all models, covariates 
were retained if their exclusion caused more than a 10% change in the beta coefficient of the full model, 
or if they improved the precision of the main effect estimate. The following covariates were considered as 
potential confounders or effect modifiers: maternal age, race/ethnicity, marital status, education, 
breastfeeding, child sex, alcohol, smoking, or drug use during pregnancy, maternal IQ (measured by the 
Peabody Picture Vocabulary test), Home Observation for Measurement of the Environment (HOME) 
score, season of urine collection, maternal PON1 activity or genotype, language spoken in the home, 
exact age at testing. Gestational age at delivery and birthweight were not evaluated for confounding 
because they are potentially causal intermediates (Moreno-Banda et al. 2009; Whyatt et al. 2004; Wolff 
et al. 2007). All models were adjusted for examiner and urinary creatinine.  
 
Results 
The Mount Sinai Children’s Environmental Health Center enrolled a multiethnic inner city cohort, the 
majority of whom were black or Hispanic women (approximately 80%) (Table 1). Most of the cohort was 
less than 25 years of age at enrollment. However, in some follow-up years, those who returned for follow-
up assessments tended to be older women, with a disproportionately low fraction of women in the 
youngest category (less than 20 years at enrollment) being unreachable by any of our contact methods. 
Similar trends were found for education. Those returning for follow up did not differ substantially from the 
originally enrolled cohort with respect to racial/ethnic composition. Importantly, there were also no 
meaningful differences with respect to breastfeeding behaviors or alcohol use during pregnancy. In 
general, mothers who returned for follow-up assessments tended to have been older at enrollment and to 
have achieved a higher level of education. Allele frequencies for PON1 polymorphisms vary by race, as 
has been previously reported for our population (Chen et al. 2003). In the population of subjects included 
in this analysis, the frequency of the A allele (resulting in Q amino acid) is 74% among whites, 36% 
among blacks, and 55% among Hispanics. The frequency of the -108T allele, and 55L alleles are also 
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differential by race. A detailed description of allele frequencies and metabolite concentrations according 
to race can be found in Supplemental Material, Table 1. 
 
At the 12-month BSID-II exam, the estimated effect of organophosphate metabolites on the MDI was 
strongly heterogeneous by race/ethnicity for the ΣDAP and ΣDMP metabolites (Table 2. Among 
nonwhites, increasing ΣDAP and ΣDMP tertiles of exposure were associated with a decrease in the MDI 
(log10 ΣDAP Beta = -3.29, 95% CI -5.88, -0.70). However, among whites, the reverse pattern emerged, 
with higher exposure associating with better MDI scores (log10 ΣDAP Beta = 4.77, 95% CI 0.69, 8.86). 
Similar trends in the effect estimates were found when we stratified by housing type (public versus 
private) rather than race/ethnicity. There was no heterogeneity in ΣDEP effect estimates according to 
race/ethnicity; and overall, ΣDEP metabolites were not associated with the 12-month BSID-II MDI. There 
was no relationship between organophosphate metabolites and the PDI at 12-months overall, and no 
interaction with race/ethnicity for any of the metabolite groups (Table 2).  At the 24-month BSID-II, effect 
estimates were not heterogeneous by race/ethnicity (data not shown). Consistent with the 12-month 
assessment, prenatal maternal ΣDAP metabolite level was inversely associated with the 24-month MDI 
(B = -2.08, 95% CI -4.60, 0.44) in multivariate adjusted models, although the effect estimates were 
attenuated relative to the 12-month estimates and measured with comparable precision (see 
Supplemental Material, Table 2). The metabolites were not associated with 24-month PDI.  
 
Because of the strong interaction between race/ethnicity and OP metabolites on the BSID-II MDI at 12-
months, we examined the interaction between the PON1 polymorphisms and ΣDAP and ΣDMP 
metabolites within strata of race/ethnicity; however, the white population was too small to further 
subdivide by genotype. Therefore we restricted this analysis to only the black or Hispanic population. 
Among blacks and Hispanics, the effects of ΣDAP, ΣDEP and ΣDMP were strongly differential according 
to PON Q192R genotype at 12-months, although not 24-months. At 12-months, children of mothers with 
the slow catalytic activity, PON1 192QQ genotype experienced an approximate 4 point decline on the 
MDI with each log10 unit increase in ΣDAP and ΣDMP biomarker level, with essentially no effect among 
children of mothers with the QR/RR genotype. Although in some instances the point estimate among the 
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QR/RR group were quite elevated in a positive direction, they were always estimated with greater 
imprecision, despite the fact that this was the larger strata (Table 3). A similar pattern was found for the 
ΣDEP-PON1 Q192R interaction, although the differences between genotypes were less pronounced.  
Results were consistent when we stratified by black and Hispanic ancestry (see Supplemental Material, 
Table 3), although the sample size was quite small. There was no interaction between the PON1 Q192R 
polymorphism and OP metabolite level on the MDI at 24-months. There were also no interactions (p ≥ 
0.20) between organophosphate metabolites and the L55M or -108C>T polymorphisms, nor with enzyme 
activity, on neurodevelopment at any age. Results were similar when we estimated associations 
according to the child’s PON1 Q192R genotype instead of the mother’s genotype, but child genotype was 
only available for 57% of the population because cord blood was only collected on a subset. Therefore, 
we report only the maternal gene-OP interactions. 
 
Increasing total DEP metabolite levels were associated with slight decrements in full scale IQ (log10 Beta 
= -2.89, 95% CI -6.15, 0.36) and perceptual reasoning (log10 Beta = -3.51, 95% CI -7.31, 0.30) on the 
combined psychometric exams, and also with Working Memory (log10 Beta = -3.48, 95% CI -7.29, 0.34) 
on the 7-9 year WISC-IV examination (Table 4), although the estimated effects were relatively modest 
and imprecise. These associations were not heterogeneous by race/ethnicity. However, for the combined 
population, there was again effect heterogeneity according to the PON1 Q192R polymorphism for the 
associations between ΣDAP and ΣDMP biomarkers and perceptual reasoning domain., Children of 
mothers with the slow catalytic activity genotype (QQ) experienced a substantial decrement in the overall 
perceptual reasoning score with each log10 increment increase in exposure, while. there was no effect of 
ΣDAP and ΣDMP biomarkers on the perceptual reasoning score of children with mothers who carried the 
QR/RR genotypes (Table 5). Comparing biomarker tertiles according to genotype, increasing tertiles of 
ΣDAP, ΣDEP and ΣDMP among the children of mothers with the PON1 192QQ genotype were generally 
associated with monotonically declining LSMEANS in FSIQ and perceptual reasoning, while there was no 
consistent pattern in the QR/RR group (Figure 1). For perceptual reasoning, the first versus third tertile 
contrasts for ΣDAP and ΣDMP were statistically significant (p < 0.05). 
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Maternal third trimester blood PCB concentration was inversely associated with mental development at 
12 months (loge beta = -7.18, 95% CI -14.47, 0.11) but not at 24 months (loge beta = 1.60, 95% CI -6.57, 
9.77), and was not associated with IQ (see Supplemental Material, Table 4). However, although the 
effect estimates for PCBs were sometimes quite large, they were also measured with extreme 
imprecision, as indicated by the very large confidence intervals. Maternal third trimester blood DDE was 
not associated with any of the outcome measures. 
 
Discussion 
We report an association between prenatal increasing ΣDAP and ΣDMP urinary metabolite 
concentrations and poorer scores on the BSID-II MDI at 12-months among blacks and Hispanics. These 
associations were modified by maternal PON1 Q192R genotype, such that negative effects appeared to 
be limited to children of mothers with the QQ genotype. Heterogeneity according to maternal 
race/ethnicity may indicate differences in exposure sources rather than any underlying susceptibility. As 
previously described, overall, 46.4% of our mothers reported that pesticides were applied in their home 
either by themselves or by a family member during their pregnancy (Berkowitz et al. 2003). However, 
there was a profound racial disparity in this behavior (Berkowitz et al. 2003). Among the women who 
returned for the 12-month BSID-II exam, 70.5% of the blacks and Hispanics reported buying pesticides, 
applying pesticides, or fumigating their house during their pregnancy, compared with only 31.6% of the 
whites, and yet we did not detect significant differences in their exposure distributions (Supplemental 
Material, Table 1). In our population, race/ethnicity was strongly associated with whether a subject lived 
in public or private housing. And indeed, similar trends in the effect estimates were found when we 
stratified by housing type (public versus private) rather than race/ethnicity, although the magnitude of the 
interaction was not as strong. This indicates that whites, or people living in private or owner-occupied 
housing, may have experienced a different source of exposure to pesticides or their metabolites that 
contributed substantially to their urinary concentrations; one possibility is that pesticide residues from 
fresh fruit and vegetable consumption account for a large fraction of the urinary metabolite levels among 
whites. Unfortunately this presents serious complications for exposure reconstruction using urinary 
metabolites. A recent examination of dialkylphosphate residues on fruits and vegetables found that over 
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half of the samples tested contained more pre-formed DAP residues than parent organophosphate 
pesticides (Zhang et al. 2008). These DAP residues were produced by abiotic hydrolysis, photolysis or 
plant metabolism (Zhang et al. 2008). Direct intake of the metabolite (i.e. pesticide residue) without the 
active oxon, rather than the parent pesticide, does not inhibit cholinesterase activity. Thus, for subjects 
for whom the primary source of pesticide exposure is fresh fruit and vegetable consumption, use of 
urinary metabolite concentrations as an indication of parent compound exposure may result in significant 
misclassification of exposure. 
 
Between the ages of 6 and 9 years, prenatal ΣDEP urinary metabolite concentrations were associated 
with slight decrements in FSIQ, Perceptual Reasoning, and Working Memory. Furthermore, among 
children of QQ mothers, ΣDAP and ΣDMP urinary metabolite concentrations were associated with poorer 
scores on Perceptual Reasoning and FSIQ in a monotonically decreasing manner. In both cases, we 
observed stronger Q192R-interactions for ΣDAP and ΣDMP urinary metabolites, rather than ΣDEP 
metabolites. The reasons for this are unclear. PON1 Q192R exhibits substrate specificity (Richter et al. 
2009), but our strongest interactions were for dimethylphosphates, not diethylphosphates (into which 
chlorpyrifos and diazinon both metabolize). An alternative explanation is that our dimethylphosphate 
metabolite concentrations were simply higher (Engel et al. 2007), indicating more available substrate. 
Unfortunately the relevant parent compounds cannot be deduced on the basis of non-specific urinary 
DAPs; however, one well publicized source of DMP exposure during the period of enrollment was 
malathion spraying for West Nile carrying mosquitos (Nash et al. 2001; O'Sullivan et al. 2005). 
Interestingly, PON1 status may indirectly influence methyl organophosphate metabolism when multiple 
organophosphate exposures are involved (Jansen et al. 2009).  
 
The estimated effects we report for the BSID-II MDI are in line with what has recently been reported in 
the CHAMACOS study, a similarly designed prospective birth cohort that was enrolled in an agricultural 
community in the Salinas Valley of California (Eskenazi et al. 2010). Eskenazi et al. report evidence of 
negative effects of ΣDAPs on the MDI, but not the PDI, and particularly among children with the QQ 
genotype, although there did not appear to be strong effect heterogeneity in the DAP-MDI relationship 
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according to PON genotype.. Although we report interactions with maternal PON1 Q192R genotype, very 
similar interactions and effect estimates were found for child genotype in our cohort (data not shown).  In 
no cases was effect heterogeneity detected according to w PON1 enzyme activity. This may be because 
genotype is a more stable, long-term predictor of metabolism potential. Reconciling estimated effects 
across studies can be complicated when only non-specific urinary metabolites are measured because 
these metabolites can derive from multiple parent compounds (2005) that may vary in the degree to with 
they interact with the Q192R genotype and influence neurodevelopment. 
 
Ours was a multi-ethnic study population recruited at an inner city tertiary care hospital that serves a 
lower income minority population. As such, attrition resulting from the challenges of maintaining contact 
with this population may have impacted our study findings. Misclassification of parent compound 
exposure according to exposure route is another significant limitation of our study and other studies 
relying on urinary DAP biomarkers, and may explain the heterogeneity in effects observed according to 
race/ethnicity in our population. It may further complicate the comparison of exposure effects across 
studies where there exists heterogeneity in exposure sources. Additionally, we measured DAP 
biomarkers at one time during pregnancy, approximately the early third trimester. Although we accounted 
for seasonal variation in exposure levels in our model, other time-related variability may result in 
additional misclassification of exposure.  
 
Finally, residual confounding by unmeasured covariates, including postnatal exposure, should be 
considered when evaluating our results. It should be noted that our study enrollment and evaluation 
periods overlapped with important regulatory changes in residential use of chlorpyrifos and diazinon, 
which occurred approximately midway through our study. Therefore, childhood exposure to these 
compounds may vary substantially pre versus post-ban, although we did not observe any significant 
interaction with study year (data not shown). However, these changes may explain the inconsistency 
between our 12 and 24-month BSID-II results. The 0-12-month exposure window may include less hand-
to-mouth childhood exposure (from crawling exposure to house dust, and/or fresh fruit and vegetable 
consumption) than in the 12-24 month window; thus, more childhood exposure in the 12-24 month 
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window may modify the effect of prenatal exposure. Nonetheless, it is likely, overall, that childhood 
exposure to chlorpyrifos and diazinon was lower post-ban (Williams et al. 2008). 
 
In conclusion, we found that prenatal maternal urinary dialkylphosphate metabolite concentrations were 
negatively associated with aspects of neurodevelopment at 12 and 24 months, and also at 6 to 9 years of 
age in an urban, inner city population. The evidence was strongest among the children of mothers with 
the PON1 192QQ genotype, which was present in approximately 30% of our population overall, although 
that varies according to racial ancestry. This important potential source of effect heterogeneity should be 
considered in future studies of organophosphate exposure. 
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Table 1.  Characteristics of the Mount Sinai Children’s Environmental Health Study, Mount Sinai Medical 
Center 1998-2002 
 
 Original 12 month  24 month 6 - 9 year 
 Enrolled Cohort Follow-up Follow-up Follow-up 
 (N = 404) (N = 200) (N = 276) (N = 169) 
  N % N % N % N % 
Maternal Age at delivery 
 < 20 years 142 35.2 57 28.5 96 34.8 54 31.9 
 20-24 years 132 32.7 56 28.0 83 30.1 56 33.1 
 25-29 years 44 10.9 30 15.0 34 12.3 25 14.8 
 30-34 years 64 15.8 39 19.5 43 15.6 19 11.2 
 ≥ 35 years 22 5.4 18 9.0 20 7.2 15 8.9 
 
Race/Ethnicity 
 White 86 21.29 57 28.5 63 22.8 31 18.3 
 Black 112 27.72 52 26.0 74 26.8 47 27.8 
 Hispanic 200 49.50 89 44.5 136 49.3 88 52.1 
 Other 6 1.49 2 1.0 3 1.1 3 1.8 
  
Marital Status 
 Married 117 29.0 71 35.5 81 29.4 38 22.5 
 Living with baby’s father 98 24.3 41 20.5 62 22.5 40 23.7 
 Single 189 46.8 88 44.0 133 48.2 91  53.9 
 
Education 
 < High School 118  29.4 50 25.0 78 28.3 46 27.2 
 High School graduate 83 20.7 35 17.5 55 19.9 36 21.3 
 Some college 103 25.6 49 24.5 70 25.4 51 30.2 
 ≥ Bachelor’s degree 98 24.4 66 33.0 73 26.5 36 21.3 
 
Alcohol Use during Pregnancy 59 14.0 31 16.0 36 13.4 28 16.9 
 
Duration of Breastfeeding 
 < 1 month 140 42.2 74 37.0 122 44.2 73 43.5 
 1-3 months 71 21.4 45 22.5 56 20.3 36 21.4 
 ≥ 4 months 121 36.5 81 40.5 98 35.5 59 35.1 
  
  Any organophosphate biomarker level 383 94.8 190 95.0 267 96.7 165 99.0 
 
Maternal PON1 Q192R 
 QQ 120 30.9 63 33.3 78 30.2 46 28.2 
 QR 174 44.7 83 43.9 119 46.1 78 47.9 
 RR 95 24.4 43 22.8 61 23.6 39 23.9 
 
Maternal paraoxonase enzyme activity (units/ml) 
 2964 – 9576 (Tertile 1) 130 33.9 69 37.5 91 35.7 57 34.8 
 9700 – 11660 (Tertile 2) 123 32.1 51 27.7 81 31.8 43 26.2 
 11665 – 20000 (Tertile 3) 130 33.9 64 34.8 83 32.6 64 39.0 
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Table 2.  Prenatal Organophosphate Biomarker Levels and 12-month BSID-II Mental Development Index in the Mount Sinai Children’s Environmental Health Study 
 





 White Subjects 
b
  
 (N = 149) (N = 111) (N = 38) 
 
 Organophosphate Biomarkers Adjusted Mean 95% CI Adjusted Mean 95% CI Adjusted Mean 95% CI interaction p-value 
  MDI  MDI  MDI 
 T3 96.1 93.1, 99.0 91.5 88.3, 94.7 103.7 98.5, 108.8 < 0.001 
ΣDAP T2 95.8 92.5, 99.1 94.4 91.2, 97.5 95.9 90.6, 101.3  
 T1 97.0 93.7, 100.3 96.2 92.9, 99.4 92.0 85.4, 98.7  
 log10 Beta (-1.00) (-3.28, 1.28) (-3.29) (-5.88, -0.70) (4.77) (0.69, 8.86) 0.001 
 
 T3 97.5 94.3, 100.6 95.2 91.9, 98.6 100.6 94.6, 106.5 0.82 
ΣDEP T2 95.4 92.3, 98.6 93.8 90.4, 97.1 96.8 90.8, 102.9  
 T1 95.9 92.9, 98.9 94.3 90.9, 97.6 97.3 91.8, 102.7  
 log10 Beta (0.03) (-2.23, 2.29) (-0.33) (-3.00 , 2.35) (0.86) (-3.16, 4.87) 0.62 
          
 T3 96.1 93.4, 99.0 92.1 89.0, 95.2 103.3 97.9, 108.7 < 0.01 
ΣDMP T2 96.1 92.9, 99.3 94.2 91.0, 97.4 97.2 91.1, 102.6  
 T1 96.8 93.5, 100.0 96.3 93.0, 99.5 92.2 85.6, 98.7  
 log10 Beta (-1.12) (-3.14, 0.89) (-3.35) (-5.64 , -1.06) (4.45) (0.82, 8.08) < 0.001 
 
   Adjusted Mean 95% CI Adjusted Mean 95% CI Adjusted Mean 95% CI interaction p-value 
  PDI  PDI  PDI 
ΣDAP T3 92.5 88.5, 96.6 94.2 89.5, 98.9 90.8 83.3, 98.2 0.65 
 T2 96.6 92.1, 101.1 97.5 93.0, 102.1 97.0 89.2, 104.7  
 T1 95.3 90.9, 99.8 97.7 93.1, 102.4 90.0 80.5, 99.6  
 log10 Beta (-0.52) (-3.66, 2.62) (-1.52) (-5.21, 2.16) (2.07) (-3.83, 7.96) 0.31 
          
ΣDEP T3 93.6 89.3, 98.0 95.6 91.0, 100.2 91.7 83.5, 99.9 0.25 
 T2 94.5 90.1, 98.9 95.9 91.2, 100.6 94.4 86.0, 102.7  
 T1 95.3 91.2, 99.5 97.7 93.1, 102.4 92.1 84.6, 99.6  
 log10 Beta (-0.20) (-3.28, 2.87) (-0.48) (-4.11, 3.16) (0.46) (-5.12, 6.03) 0.78 
          
ΣDMP T3 94.5 90.6, 98.5 96.4 92.0, 100.8 92.5 84.9, 100.2 0.83 
 T2 93.7 89.3, 98.0 94.5 90.1, 99.0 94.4 86.7, 102.1  
 T1 95.1 90.7, 99.5 97.8 93.2, 102.4 89.5 80.2, 98.8  




General linear model adjusted for race/ethnicity, maternal age at enrollment, child sex, examiner, maternal PON1 enzyme activity, season of urine collection, laboratory batch, 
HOME Score, alcohol consumption during pregnancy, and urinary creatinine.  
 
b
 General linear model adjusted for maternal age at enrollment, child sex, examiner, maternal PON1 enzyme activity, season of urine collection, laboratory batch, HOME Score, 
alcohol consumption during pregnancy, and urinary creatinine, and including a biomarker-race interaction term. 
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Table 3 PON1 Q192R Interaction with Total Dialkyl and Dimethylphosphate Biomarker levels on the BISD-II Mental Development Index in the 
Mount Sinai Children’s Environmental Health Study 
 
 
 12-MONTH BSID-II 24-MONTH BSID-II 
 Black/Hispanic Subjects Total Population 
 N = 110
c 
N = 191 
 
 PON1 192 QR/RR (FAST) PON1 192 QQ (SLOW)
b 
PON1 192 QR/RR (FAST) PON1 192 QQ (SLOW) 
 N = 82 N = 28 N = 140 N = 57 
 
 log10 Beta 95% CI log10 Beta 95% CI interaction p-value log10 Beta 95% CI log10 Beta 95% CI interaction p-value 
 ΣDAP
a
  5.45 -0.79, 11.69 -4.71 -7.59, -1.83 <0.01 -1.04 -6.06, 3.99 -1.27 -4.40, 1.84 0.93 
 ΣDEP
a
 3.55 -1.14, 8.23 -1.60 -4.99, 1.79 0.08 -0.55 -4.79, 3.70 -0.15 -3.51, 3.21 0.88 
 ΣDMP
a
 2.52 -2.71, 7.74 -4.30 -6.89, -1.71 0.02 0.12 -4.17, 4.42 -0.48 -3.27, 2.30 0.81 
 
 
a General linear model adjusted for maternal age at enrollment, child sex, examiner, HOME Score, alcohol consumption during pregnancy, 
laboratory batch, season of urine collection, urinary creatinine, and including a biomarker-PON1 Q192R genotype interaction. The 24-month model 
was additionally adjusted for maternal race/ethnicity. 
b Note that in this category, 7 are black and the remainder Hispanic. 
c Note that 1 subject identified mixed ethnicity 
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Table 4 Prenatal Organophosphate Biomarker Levels and Psychometric Intelligence at 6-9 years in the Mount Sinai Children’s Environmental 
Health Study 
 
 log10 ΣDAP log10 ΣDEP log10 ΣDMP 
Combined Populations (6-9 years)
a 
N Beta 95% CI N Beta 95% CI N Beta 95% CI  
Full Scale IQ 140 -1.39 -4.54, 1.77 140 -2.89 -6.15, 0.36 142 -0.46 -3.17, 2.26 
Perceptual Reasoning  -2.36 -6.04, 1.31  -3.51 -7.31, 0.30  -1.15 -4.31, 2.02 
Verbal Comprehension  -0.42 -3.45, 2.62  -1.20 -4.35, 1.96  -0.05 -2.64, 2.54 
 
 
 log10 ΣDAP log10 ΣDEP log10 ΣDMP 
WISC-IV (7-9 years) 
a
  N Beta 95% CI N Beta 95% CI N Beta 95% CI  
Full Scale IQ 114 -1.10 -5.01, 2.81 114 -3.15 -7.19, 0.89 115 -0.39 -3.64, 2.86 
Perceptual Reasoning  -2.39 -6.97, 2.19  -4.37 -9.10, 0.36  -1.24 -5.05, 2.57 
Verbal Comprehension  0.56 -3.11, 4.23  -0.08 -3.91, 3.76  0.39 -2.65, 3.42 
Processing Speed  -1.05 -5.57, 3.46  -2.11 -6.81, 2.59  -0.79 -4.52, 2.94 
Working Memory  -0.53 -4.24, 3.18  -3.48 -7.29, 0.34  0.29 -2.81, 3.38 
 
 
 log10 ΣDAP log10 ΣDEP log10 ΣDMP 
WPPSI-III (6 years) 
a
  N Beta 95% CI N Beta 95% CI N Beta 95% CI  
Full Scale IQ 96 -1.14 -4.55, 2.28 96 -1.40 -5.27, 2.47 98 -0.56 -3.68, 2.56 
Perceptual Reasoning  -2.07 -5.66, 1.52  -1.59 -5.68, 2.50  -1.46 -4.74, 1.83 
Verbal Comprehension  -1.16 -4.59, 2.27  -2.27 -6.14, 1.60  -0.52 -3.67, 2.62 
Processing Speed  -1.22 -5.12, 2.67  -1.85 -6.25, 2.56  -0.84 -4.35, 2.67 
 
a Generalized linear models adjusted for sex, race/ethnicity, maternal education, language in the home, maternal PON1 enzymatic activity, alcohol 
use in pregnancy, batch season of urine collection, and urinary creatinine. Combined Population models additionally adjusted for whether the score 
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Table 5 Joint Prenatal Organophosphate Biomarker and PON1 Q192R Effect on Combined IQ Domains at 6-9 years in the Mount Sinai Children’s 
Environmental Health Study 
 
 FSIQ FSIQ 
 PON1 192 QR/RR (Fast) PON1 192 QQ (Slow) 
 N = 101 N = 39 
 Beta 95% CI Beta 95% CI interaction p-value 
log10 ΣDAP
a
 -0.66 -4.33, 3.00 -2.33 -8.40, 3.74 0.64 
log10 ΣDEP
a
 -2.32 -6.49, 1.86 -3.13 -8.21, 1.96 0.80 
log10 ΣDMP
a
 0.28 -2.89, 3.44 -1.79 -6.83,  3.25 0.49 
 
 Perceptual Reasoning Perceptual Reasoning 
 PON1 192 QR/RR (Fast) PON1 192 QQ (Slow) 
 Beta 95% CI Beta 95% CI interaction p-value 
log10 ΣDAP
a
 -0.56 -4.80, 3.68 -7.52 -14.53, -0.51 0.09 
log10 ΣDEP
a
 -3.24 -8.11, 1.62 -4.80 -10.73, 1.13 0.68 
log10 ΣDMP
a
 0.71 -2.96, 4.38 -6.15 -11.99,  -0.31 0.05 
 
 Verbal Comprehension Verbal Comprehension 
 PON1 192 QR/RR (Fast) PON1 192 QQ (Slow) 
 Beta 95% CI Beta 95% CI interaction p-value 
log10 ΣDAP
a
 -0.33 -3.87, 3.20 -0.73 -5.12, 6.59 0.76 
log10 ΣDEP
a
 -0.45 -4.51, 3.60 -1.20 -6.13, 3.74 0.81 
log10 ΣDMP
a
 0.12 -2.93, 3.16 0.24 -4.60, 5.09 0.97 
 
 
a Generalized linear models adjusted for sex, race/ethnicity, maternal education, language in the home, alcohol use in pregnancy, batch season of 
urine collection, urinary creatinine, and an indicator variable to designate the WISC-IV or WPPSI-III instrument.  
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Figure 1 Legend 
 
Multivariate adjusted mean estimates and 95% confidence limits according to tertiles of exposure and 
PON1 Q192R genotype are presented. Among the children of mothers with the PON1 192QQ genotype 
(black triangles), increasing tertile of ΣDAP, ΣDEP and ΣDMP exposure was generally associated with a 
monotonic decline in the combined WISC-IV/WPPSI-III FSIQ and Perceptual Reasoning domains, 
adjusted for sex, race/ethnicity, maternal education, language in the home, alcohol use in pregnancy, 
batch and season of urine collection, urinary creatinine, and an indicator variable to designate the WISC-
IV or WPPSI-III instrument. There were no consistent patterns in the QR/RR genotype group (gray 
squares). There was considerable imprecision in all estimates. The 1st versus 3rd tertile contrasts for 
Perceptual Reasoning were significantly different at p < 0.05 for ΣDAP and ΣDMP. Overall these results 
suggest a role for genetic susceptibility in the deleterious effects of prenatal pesticide exposure. 
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